Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
6.12
+0.96 (18.72%)
At close: Aug 28, 2026, 4:00 PM EDT
5.70
-0.42 (-6.86%)
After-hours: Aug 28, 2026, 7:59 PM EDT
Quoin Pharmaceuticals Employees
As of December 31, 2025, Quoin Pharmaceuticals had 6 total employees, including 4 full-time and 2 part-time employees. The number of employees increased by 1 or 20.00% compared to the previous year.
Employees
6
Change (1Y)
1
Growth (1Y)
20.00%
Revenue / Employee
n/a
Profits / Employee
-$3,110,886
Market Cap
12.29M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 6 | 1 | 20.00% | 4 | 2 |
| Dec 31, 2024 | 5 | 1 | 25.00% | 3 | 2 |
| Dec 31, 2023 | 4 | 0 | - | 4 | 0 |
| Dec 31, 2022 | 4 | 0 | - | 4 | 0 |
| Dec 31, 2021 | 4 | 2 | 100.00% | 4 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Vistagen Therapeutics | 41 |
| Senti Biosciences Holdings | 39 |
| BioLineRx | 24 |
| Daré Bioscience | 24 |
| PDS Biotechnology | 21 |
| Moleculin Biotech | 17 |
| Theriva Biologics | 16 |
| Kiora Pharmaceuticals | 13 |
QNRX News
- 2 days ago - Quoin Pharmaceuticals announces $50M private placement - TheFly
- 2 days ago - Quoin Pharmaceuticals reports ‘positive’ data from Phase 2/3 study of QRX003 - TheFly
- 2 days ago - Quoin Pharmaceuticals Reports Positive Interim Data from Ongoing Phase 2/3 Study of QRX003 in Netherton Syndrome - GlobeNewsWire
- 2 days ago - Quoin Pharmaceuticals Announces Private Placement Financing of Up to $50.0 Million - GlobeNewsWire
- 14 days ago - Quoin Pharmaceuticals reports Q2 EPS ($1.90), consensus ($1.77) - TheFly
- 16 days ago - Quoin Pharmaceuticals Earnings release: Q2 2026 - Filings
- 16 days ago - Quoin Pharmaceuticals Quarterly report: Q2 2026 - Filings
- 16 days ago - Quoin Pharmaceuticals Earnings release: Q2 2026 - Filings